BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2069843)

  • 1. Lipid mobilising factors specifically associated with cancer cachexia.
    Beck SA; Tisdale MJ
    Br J Cancer; 1991 Jun; 63(6):846-50. PubMed ID: 2069843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo.
    Russell ST; Tisdale MJ
    Br J Cancer; 2002 Aug; 87(5):580-4. PubMed ID: 12189560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of a lipid-mobilizing factor associated with cachexia-inducing tumors in mice and humans.
    McDevitt TM; Todorov PT; Beck SA; Khan SH; Tisdale MJ
    Cancer Res; 1995 Apr; 55(7):1458-63. PubMed ID: 7882353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipolytic factors associated with murine and human cancer cachexia.
    Beck SA; Mulligan HD; Tisdale MJ
    J Natl Cancer Inst; 1990 Dec; 82(24):1922-6. PubMed ID: 2250313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of glucocorticoids in the induction of zinc-alpha2-glycoprotein expression in adipose tissue in cancer cachexia.
    Russell ST; Tisdale MJ
    Br J Cancer; 2005 Mar; 92(5):876-81. PubMed ID: 15714206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of eicosapentaenoic acid (EPA) on expression of a lipid mobilizing factor in adipose tissue in cancer cachexia.
    Russell ST; Tisdale MJ
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jun; 72(6):409-14. PubMed ID: 15899583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients.
    Cariuk P; Lorite MJ; Todorov PT; Field WN; Wigmore SJ; Tisdale MJ
    Br J Cancer; 1997; 76(5):606-13. PubMed ID: 9303359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour.
    Mahony SM; Beck SA; Tisdale MJ
    Br J Cancer; 1988 Apr; 57(4):385-9. PubMed ID: 3390373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer cachexia.
    Tisdale MJ
    Langenbecks Arch Surg; 2004 Aug; 389(4):299-305. PubMed ID: 15168125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catabolic factors in cancer cachexia.
    Tisdale MJ; McDevitt TM; Todorov PT; Cariuk P
    In Vivo; 1996; 10(2):131-6. PubMed ID: 8744791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients.
    Groundwater P; Beck SA; Barton C; Adamson C; Ferrier IN; Tisdale MJ
    Br J Cancer; 1990 Nov; 62(5):816-21. PubMed ID: 2245173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a novel serum factor distinct from zinc alpha-2 glycoprotein that promotes body fat loss early in the development of cachexia.
    Byerley LO; Lee SH; Redmann S; Culberson C; Clemens M; Lively MO
    Nutr Cancer; 2010; 62(4):484-94. PubMed ID: 20432169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients.
    Hirai K; Hussey HJ; Barber MD; Price SA; Tisdale MJ
    Cancer Res; 1998 Jun; 58(11):2359-65. PubMed ID: 9622075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipolytic and thermogenic depletion of adipose tissue in cancer cachexia.
    Tsoli M; Swarbrick MM; Robertson GR
    Semin Cell Dev Biol; 2016 Jun; 54():68-81. PubMed ID: 26529279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EPA-enriched phospholipids ameliorate cancer-associated cachexia mainly via inhibiting lipolysis.
    Du L; Yang YH; Wang YM; Xue CH; Kurihara H; Takahashi K
    Food Funct; 2015 Dec; 6(12):3652-62. PubMed ID: 26373883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid metabolism in cancer cachexia.
    Mulligan HD; Beck SA; Tisdale MJ
    Br J Cancer; 1992 Jul; 66(1):57-61. PubMed ID: 1637677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of a tumor lipid-mobilizing factor.
    Todorov PT; McDevitt TM; Meyer DJ; Ueyama H; Ohkubo I; Tisdale MJ
    Cancer Res; 1998 Jun; 58(11):2353-8. PubMed ID: 9622074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study.
    Christensen HM; Kistorp C; Schou M; Keller N; Zerahn B; Frystyk J; Flyvbjerg A; Faber J
    Metabolism; 2014 Jan; 63(1):141-9. PubMed ID: 24140097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer.
    Silvério R; Lira FS; Oyama LM; Oller do Nascimento CM; Otoch JP; Alcântara PSM; Batista ML; Seelaender M
    Lipids Health Dis; 2017 Aug; 16(1):159. PubMed ID: 28830524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning.
    Han J; Meng Q; Shen L; Wu G
    Lipids Health Dis; 2018 Jan; 17(1):14. PubMed ID: 29338749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.